Follow the 진원생명과학 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 진원생명과학 has published 60 reports. Market capitalisation: €9.7bn. The latest transaction was disclosed on 1 June 2026 (Other). Among the most active insiders: 박영근. Every trade is openly available.
60
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
19 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.